U.S. Biotech Stock News

If you are wondering whether SLB is priced attractively right now, you are not alone. Many investors are asking if the current share price lines up with the underlying value of the business. SLB shares last closed at US$46.97, with returns of 10.9% over 7 days, 20.7% over 30 days, 16.8% year to date, 19.2% over 1 year and a 106.3% gain over 5 years, set against an 11.4% decline over 3 years that may still be in the back of some holders' minds. Recent coverage has focused on SLB's role as a...

Q.E.P (QEPC) has put another quarter on the board, with Q3 2026 revenue of US$59.1 million and basic EPS of US$1.08, while trailing 12 month EPS sits at US$4.56 on revenue of US$235.0 million and net income of US$14.8 million. Over recent quarters the company has seen revenue move between US$56.7 million and US$62.6 million and quarterly EPS range from US$1.03 to US$1.41. This gives investors a clearer view of how earnings power translates into the current 6.3% net margin. Overall, the latest...

NuScale Power (SMR) is back on watch for investors after recent share price moves, with the stock closing at US$19.83 as shorter term returns contrast sharply with its past 3 months performance. See our latest analysis for NuScale Power. The recent 1 day share price return of 3.12% and 1 month share price return of 13.90% sit against a 90 day share price return decline of 58.38%. At the same time, the 3 year total shareholder return of 91.41% and 5 year total shareholder return of 81.93%...

Investor focus on UiPath (PATH) has picked up after the company said its Screen Agent, powered by Claude Opus 4.5, ranked first on the OSWorld Verified benchmark for agentic AI deployments. See our latest analysis for UiPath. Even with the Screen Agent milestone and growing attention on its AI roadmap, UiPath’s short-term share price performance has been weak, with a 7 day share price decline of 13.85% and a 1 day share price decline of 3.76%. Its 1 year total shareholder return of 14.96% and...

Why Bristol-Myers Squibb (BMY) is Back on Investors’ Radar Bristol-Myers Squibb (BMY) has drawn fresh attention after a recent move in its share price, with the stock closing at $57.02. That puts renewed focus on how its current valuation lines up with business fundamentals. See our latest analysis for Bristol-Myers Squibb. The recent 1 day share price return of 1.97% and 30 day share price return of 5.03% sit within a much stronger 90 day share price return of 31.41%. The 1 year total...

Recently, hedge fund Viking Global Investors boosted its stake in Chewy by very large, adding over 8 million shares and bringing its total ownership to about 13.5 million shares, signaling increased confidence in the pet e-commerce retailer’s long-term direction. This move highlights how a major institutional investor appears to view Chewy’s recurring, subscription-heavy revenue model as an important asset amid recent operational challenges. We’ll now examine how Viking Global’s larger...

Tyson Foods (TSN) is back in focus for investors after recent share price moves, with returns of 0.6% over the past day and 7.5% over the past week drawing attention. See our latest analysis for Tyson Foods. Those short term gains come on top of a 90 day share price return of 15.87% and a 1 year total shareholder return of 12.25%. This suggests momentum has been building recently from a relatively steady longer term base. If Tyson Foods has you rethinking your portfolio, this could be a...

Western Alliance Bank recently appointed David Hutzler as head of its Private Client Group in Las Vegas, which serves high-net-worth clients with concierge banking and mortgage services. This leadership move comes as Western Alliance Bancorporation reported third-quarter revenue of US$921.4 million and net income of US$261 million, both exceeding analyst expectations and delivering record pre-provision net revenue. Next, we will examine how these stronger-than-expected quarterly results and...

Trinity Capital (TRIN) caught investor attention after reporting record 2025 activity, with US$2.1b in new investment commitments and US$1.5b funded, ahead of its detailed financial results expected on February 25, 2026. See our latest analysis for Trinity Capital. Trinity Capital’s record 2025 commitments appear to sit alongside strengthening market sentiment, with a 30-day share price return of 6.73% and a 1-year total shareholder return of 27.91%. This suggests momentum has been building...

Citizens Financial Group (CFG) has drawn fresh attention after posting annual revenue of US$7,443.0 million and net income of US$1,566.0 million, putting the regional bank’s scale and profitability in clearer focus for investors. See our latest analysis for Citizens Financial Group. At a share price of US$59.93, Citizens Financial Group has seen a 23.85% 90 day share price return, while its 1 year total shareholder return of 32.18% and 5 year total shareholder return of 84.92% reflect...

In early January 2026, Cursor announced a partnership with EPAM Systems to roll out generative AI–native engineering workflows across large enterprise development teams worldwide, combining Cursor’s AI coding platform with EPAM’s more than 50,000 engineers and delivery frameworks. This collaboration underscores how EPAM is turning its internal AI investments into client-facing solutions that aim to change how software is built at scale. Next, we’ll examine how EPAM’s expanded AI-native...

Fresh attention is on Devon Energy (DVN) after recent analyst commentary and an Investing.com feature highlighted its free cash flow profile and value credentials, even as some firms point to short term oil price headwinds. See our latest analysis for Devon Energy. The recent focus on Devon’s free cash flow and value credentials comes after a strong 90 day share price return of 18.39% and a one year total shareholder return of 1.42%. The three year total shareholder return of 31.61% contrasts...

Commercial Metals (CMC) is back in focus after first quarter 2025 results showed sales of US$2.12b and net income of US$177.28m, compared with a net loss a year earlier. See our latest analysis for Commercial Metals. The earnings release and the recent dividend affirmation on 5 January appear to sit against a strong backdrop, with a 90 day share price return of 34.16% and a 1 year total shareholder return of 45.91% suggesting positive momentum around both growth expectations and perceived...

AtaiBeckley (ATAI) shares are in focus after the company paired fresh 2026 clinical milestones and a new EMP-01 patent with its recent move to a Delaware holding structure and ongoing J.P. Morgan Healthcare Conference outreach. See our latest analysis for AtaiBeckley. Despite the fresh 2026 pipeline milestones, EMP-01 patent news and the recent Delaware redomiciliation, AtaiBeckley’s 1 day share price return of 1.36% to US$3.72 comes after a 90 day share price return decline of 32.12%, while...

If you are wondering whether Hubbell's current share price lines up with its underlying value, you are not alone. This article will walk through what the numbers actually say. At a last close of US$476.06, the stock has returns of 1.7% over 7 days, 7.0% over 30 days, 2.8% year to date, 12.5% over 1 year, 117.7% over 3 years and 210.6% over 5 years, which naturally raises questions about where value stands today. Recent attention on Hubbell has been shaped by broader interest in capital goods...

In recent days, coverage of MercadoLibre has emphasized its rapid growth in items sold and payment volume, extensive in-house logistics handling the vast majority of deliveries, and expanding fintech and advertising operations across Latin America, even as some analysts anticipate an earnings-per-share decline in the upcoming results. These reports highlight a company that is simultaneously drawing bullish attention for its entrenched e-commerce and fintech ecosystem and cautious scrutiny...

Saul Centers (BFS) has been drawing attention after recent share performance data showed a mix of shorter term gains and longer term weakness, prompting fresh questions about how its real estate portfolio is currently being valued. See our latest analysis for Saul Centers. The recent 8.5% 90 day share price return suggests some momentum is building off the current US$32.51 level, although the 1 year total shareholder return of a 4.6% decline contrasts with the stronger 5 year total...

Recent interest in Figma (FIG) has picked up as analyst coverage highlights its new AI powered tools, including the Figma App for ChatGPT, while also raising questions about rising competition and how firmly its AI design position holds. See our latest analysis for Figma. Figma’s recent AI announcements and mixed analyst commentary have come alongside pressure on the stock, with a 90 day share price return of 44% decline and a year to date share price return of 13.96% decline. This suggests...

If you are wondering whether Samsara's current share price reflects its true worth, you are not alone. This article walks through what that price actually implies about the business. Samsara's share price closed at US$33.85, with returns of a 6.8% decline over 7 days, a 14.7% decline over 30 days, a 0.2% decline year to date, a 25.9% decline over 1 year, and a very large 3 year gain of 171.7%. These moves sit against a backdrop of regular coverage highlighting Samsara's role in connected...

Piper Sandler Companies recently reshaped its leadership bench, appointing J.P. Peltier as global co-head of investment banking and capital markets, naming new co-heads across healthcare, consumer and equity capital markets, and adding Dan Wolf as a managing director in healthcare investment banking. Together, these appointments emphasize Piper Sandler’s intent to deepen its healthcare and consumer franchises by pairing long-tenured internal leaders with an experienced return hire from the...

On January 6, 2026, a Montana federal judge refused to dismiss a class-action lawsuit alleging DuPont/Chemours and other manufacturers concealed PFAS risks in firefighter turnout gear, allowing RICO and multi-state claims to proceed. The ruling keeps Chemours exposed to potentially very large gear-replacement costs for over one million firefighters, as well as heightened scrutiny of its historical PFAS disclosures and product safety practices. We’ll now examine how this expanded PFAS...

Ameresco and Republic Services announced that in December they brought a renewable natural gas facility online at the Upper Rock Island County Landfill in East Moline, Illinois, upgrading 2,000 standard cubic feet per minute of landfill gas into pipeline-quality RNG expected to produce more than 500,000 Dekatherms annually. This 16th joint RNG project, which is expected to avoid more than 27,000 metric tons of CO2 emissions each year, reinforces Republic Services’ progress toward its 2030...

If you are wondering whether West Pharmaceutical Services is offering fair value at around US$274.98 per share, you are not alone. This article looks at what the current price might be implying. The share price has had a mixed run, with a 1.2% decline over the last week, a 1.1% gain over the last month, year to date returns of a 0.5% decline, a 16.2% decline over 1 year, an 8.9% return over 3 years and an 8.8% decline over 5 years. Recent attention around West Pharmaceutical Services has...

Sonos (SONO) has expanded its Board of Directors by adding Carmine Arabia from Meta, Mandy Fields from e.l.f. Beauty, and former Pandora chief Joe Kennedy, a shift that could matter for investors watching governance and execution. See our latest analysis for Sonos. At a share price of $16.20, Sonos has seen weaker momentum recently, with a 30 day share price return of an 11.62% decline, while the 1 year total shareholder return of 13.84% contrasts with a 5 year total shareholder return of a...